Country: United States
Language: English
Source: NLM (National Library of Medicine)
SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698), POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152, CHLORIDE ION - UNII:Q32ZN48698)
Hospira, Inc.
SODIUM CHLORIDE
SODIUM CHLORIDE 4.5 g in 1000 mL
INTRAVENOUS
PRESCRIPTION DRUG
Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes. None known. To Open Tear outer wrap at notch and remove solution container. If supplemental medication is desired, follow directions below before preparing for administration. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. To Add Medication - Prepare additive port. Prepare additive port. - Using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. Withdraw needle after injecting medication. Using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. Withdraw needle after injecting medication. - The additive port may be protected by covering with an a
20 mEq/L Potassium Chloride in 0.45% Sodium Chloride Injection, USP is supplied in 1000 mL single-dose flexible plastic containers (NDC 0409-9257-39). Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing. Revised: June, 2008 Printed in USA EN-1811 Hospira, Inc., Lake Forest, IL 60045 USA
Abbreviated New Drug Application
POTASSIUM CHLORIDE IN SODIUM CHLORIDE- SODIUM CHLORIDE AND POTASSIUM CHLORIDE INJECTION, SOLUTION HOSPIRA, INC. ---------- POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION, USP FLEXIBLE PLASTIC CONTAINER R only DESCRIPTION Potassium Chloride in Sodium Chloride Injection, USP is a sterile, nonpyrogenic, solution for fluid and electrolyte replenishment in a single dose container for intravenous administration. It contains no antimicrobial agents. Composition, osmolarity, pH and ionic concentration are shown in Table 1. TABLE 1: 20 MEQ/ L POTASSIUM CHLORIDE IN 0.45% SODIUM CHLORIDE INJ., USP COMPOS ITION (G/L) CALCULATED OS MOLARITY (MOS MOL/L) PH (RANGE) IONIC CONCENTRATIONS (MEQ/L) NDC NO. SIZE (ML) SODIUM CHLORIDE (NACL) POTAS S IUM CHLORIDE (KCL) SODIUM (NA ) POTAS S IUM (K ) CHLORIDE (CL ) 0409-9257-39 1000 4.5 1.49 194 4.8 (3.5 to 6.5) 77 20 97 The flexible plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers. CLINICAL PHARMACOLOGY Potassium Chloride in Sodium Chloride Injection, USP has value as a source of water and electrolytes. It is capable of inducing diuresis depending on the clinical condition of the patient. INDICATIONS AND USAGE Potassium Chloride in Sodium Chloride Injection, USP is indicated as a source of water and electrolytes. CONTRAINDICATIONS None known. WARNINGS x + + - Potassium Chloride in Sodium Chloride Injection, USP should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention. Potassium Chloride in Sodium Chloride Read the complete document